Molecular epidemiology: Recent advances and future directions

Carcinogenesis

Volumn 21, Issue 3, 2000, Pages 517-524

  Perera, Frederica P ^a   Weinstein, I Bernard ^a  

^a New York State Psychiatric Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CARCINOGEN; CELL CYCLE PROTEIN; CYCLINE; DNA; GROWTH FACTOR; INSULIN; NITRIC OXIDE; NITRITE; TRANSCRIPTION FACTOR;

CANCER; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIET; DNA DAMAGE; DNA METHYLATION; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENETIC EPIDEMIOLOGY; HIGH RISK POPULATION; NUTRITION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0034012368     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.3.517     Document Type: Review

References (86)

1. Perera, F.P. and Weinstein, I.B. (1982) Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J. Chron. Dis., 35, 581-600.
2. Perera, F.P. (1987) Molecular cancer epidemiology: a new tool in cancer prevention. J. Natl Cancer Inst., 78, 887-898.
3. Hulka, B.S. (1991) Epidemiological studies using biological markers: issues for epidemiologists. Cancer Epidemiol. Biomarkers Prev., 1, 13-19.
4. Harris, C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res., 51 (suppl.), 5023S-5044S.
5. Schulte, P.A. and Perera, F.P. (eds) (1993) Molecular Epidemiology: Principles and Practices. Academic Press, New York, NY.
6. IARC (1994) Intereaction of cancer susceptibility genes and environmental carcinogens. Cancer Res., 54, 4243-4247.
7. Ambrosone, C. and Kadlubar, F. (1997) Toward an integrated approach to molecular epidemiology. Am. J. Epidemiol., 146, 912-918.
8. Perera, F.P. (1997) Environment and cancer: who are susceptible? Science, 278, 1068-1073.
9. ACS (1996) Cancer Facts and Figures, 1996. American Cancer Society, Atlanta, GA.
10. Weinstein, I.B., Santella, R.M. and Perera, F.P. (1993) The molecular biology and molecular epidemiology of cancer. In P. Greenwald,P. (ed.) The Science and Practice of Cancer Prevention and Control. Marcel-Dekker, New York, NY.
11. Hulka, B.S., Griffith, J.D. and Wilcosky, T.C. (1990) Biologic Markers in Epidemiology. Oxford University Press, New York, NY.
12. Omenn, G.S. (1991) Future research directions in cancer ecogenetics. Mutat. Res., 247, 283-291.
13. Schulte, P.A. and Sweeney,M.H. (1995) Ethical considerations, confidentiality issues, rights of human subjects and uses of monitoring data in research and regulation. Environ. Health Perspect., 103 (Suppl. 3), 69-74.
14. Anonymous (1987) Biological markers in environmental health research. Committee on Biological Markers of the National Research Council. Environ. Health Perspect., 74, 3-9.
15. Coggon, D. and Friesen, M. (1997) Markers of internal dose: chemical agents. In Toniolo, P., Boffetta, P., Shuker, D., Rothman, N., Hulka, B. and Pearce, N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications No. 142, IARC, Lyon, pp. 95-102.
16. Rothman, N., Shield, P.G., Poirier, M.C., Harrington, A.M., Ford, D.P. and Strickland, P. (1995) The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotype on white-blood cell polycylic aromatic hydrocarbon-DNA adduct levels in humans. Mol. Carcinog., 14, 63-68.
17. Bartsch, J. and Hietanen, E. (1996) The role of individual susceptiblity in cancer burden related to environmental exposure. Environ. Health Perspect., 104 (Suppl. 3), 569-577.
18. Hemminki, K. (1997) DNA adducts and mutations in occupational and environmental biomonitoring. Environ. Health Perspect., 105 (Suppl. 4), 832-827.
19. Anderson, M.W. and Stowers, S.J. (1984) Ubiquitous binding of benzo(a)pyrene metabolites to DNA and protein in tissues of the mouse and rabbit. Chem. Biol. Interact., 51, 151.
20. Mooney, L.A., Santella, R.M., Covey, L., Jeffrey, A.M., Bigbee, W., Randall, M.C., Cooper, T.B., Ottman, R., Tsai, W.-Y., Wazneh, L. et al. (1995) Decline in DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol. Biomarkers Prev., 4, 627-634.
21. Perera, F.P., Poirier, M.C., Yuspa, S.H., Nakayama, J., Jaretzki, A., Curnen, M.M., Knowles, D.M. and Weinstein, I.B. (1982) A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene-DNA adducts in animal and human tissues by immunoassays. Carcinogenesis, 3, 1405-1410.
22. Santella, R.M. (1990) Immunologic methods for the detection of carcinogen adducts in humans. Basic Life Sci., 53, 33-44.
23. Poirier, M.C. (1991) Development of immunoassays for the detection of carcinogen-DNA adducts. In Groopman, J.D. and Skipper, P.L. (eds) Molecular Dosimetry and Human Cancer: Analytical, Epidemiological and Social Considerations. CRC Press Inc., Boca Raton, FL, pp. 211-230.
24. 32P-post-labelling assay. Mutat. Res., 378, 1-12.
25. Herron, D. and Shank, R. (1980) Methylated purines in human liver DNA after probable dimethylnitrosamine poisoning. Cancer Res., 40, 3116-3117.
26. Skipper, P.L. and Tannenbaum, S.R. (1990) Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis, 11, 507-518.
27. Wild, C. and Pisani, P. (1997) Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology. In Toniolo, P., Boffetta, P., Shuker, D., Rothman, N., Hulka, B. and Pearce, N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications No. 142, IARC, Lyon, pp. 143-156.
28. Poirier, M. and Weston, A. (1991) DNA adduct determination in humans. Prog. Clin. Biol. Res., 372, 205-218.
29. Tang, D.L., Chiamprasert, S., Santella, R.M. and Perera, F.P. (1995) Molecular epidemiology of lung cancer: carcinogen-DNA adducts, GSTM1 and risk. Proc. Am. Assoc. Cancer Res., 36, 284.
30. Ross, R.K., Yuan, J.M., Yu, M.C., Wogan, G.N., Qian, G.S., Tu, J.P., Groopman, J.D., Gao, Y.T. and Henderson, B.E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
31. Groopman, J.D., Wogan, G.N., Roebuck, B.D. and Kensler, T.W. (1994) Molecular biomarkers for aflatoxins and their application to human cancer prevention. Cancer Res., 54, 1907s-1911s.
32. Yu, M., Lien, J., Chiu, Y., Santella, R., Liaw, Y. and Chen, C. (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J. Hepatol., 27, 320-330.
33. Bryant, M.S., Skipper, P.L., Tannenbaum, S.R. and Niure, M. (1987) Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res., 47, 612-618.
34. Perera, F.P. (1994) Biomarkers and Molecular Epidemiology of Cancer. Proceedings of the 9th International Symposium in Epidemiology in Occupational Health, 1992. National Institute for Occupational Safety and Health, Cincinnati, OH, pp. 54-66.
35. Dickey, C., Santella, R., Hattis, D., Tang, D., Hsu, Y., Cooper, T., Young, T. and Perera, F. (1997) Variability in PAH-DNA adduct measurements in peripheral mononuclear cells: implications for quantitative cancer risk assessment. Risk Anal., 17, 649-655.
36. 1-treated rat liver and human oral mucosal cells. Cancer Res., 56, 683-688.
37. Erlich, H.A., Gelfand, D. and Sninsky, J.J. (1991) Recent advances in the polymerase chain reaction. Science, 252, 1642-1651.
38. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-52.
39. Denissenko, M.P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science, 274, 430-432.
40. Gazdar, A. and Minna, J. (1999) Molecular detection of early lung cancer. J. Natl Cancer Inst., 91, 299-301.
41. Weinstein, I.B. (1995) The contributions of molecular biology to cancer epidemiology. Ann. N Y Acad. Sci., 768, 30-40.
42. Zhou, P., Jiang, W., Weghorst, C. and Weinstein, I. (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res., 56, 36-39.
43. Caporaso, N. and Goldstein, A. (1997) Issues involving biomarkers in the study of the genetics of human cancer. In Toniolo, P., Boffetta, P., Shuker, D., Rothman, N., Hulka, B. and Pearce, N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications No. 142, IARC, Lyon, 237-250.
44. Garte, S., Zocchetti, C. and Taioli, E. (1997) Gene-environment interactions in the application of biomarkers of cancer susceptibility in epidemiology. In Toniolo, P., Boffetta, P., Shuker, D., Rothman, N., Hulka, B. and Pearce, N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications No. 142, IARC, Lyon, p. 251.
45. Schulte, P., Hunter, D. and Rothman, N. (1997) Ethical and social issues in the use of biomarkers in epidemiological studies. In Toniolo, P., Boffetta, P., Shuker, D., Rothman, N., Hulka, B. and Pearce, N. (eds) Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications No. 142, IARC, Lyon, p. 313.
46. Knudson, A.G. (1994) Hereditary cancer, oncogenes and antioncogenes. Cancer Res., 45, 1437-1443.
47. Venitt, S. (1994) Mechanisms of carcinogenesis and individual susceptibility to cancer. Clin. Chem., 40, 1421-1425.
48. Cavenee, W.K. and White, R.L. (1995) The genetic basis of cancer. Sci. Am., 272, 72-79.
49. Petruzzelli, S., Camus, A.M., Carozzi, L., Ghelarducci, L., Rindi, M., Menoconi, G., Angeletti, C.A., Ahotupa, M., Hietanen, E., Aitio, A. et al. (1988) Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients. Cancer Res., 48, 4695-4700.
50. Schweikl, H., Taylor, J.A., Kitareewan, S., Linko, P., Nagorney, D. and Goldstein, J.A. (1993) Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics, 3, 239-249.
51. Kellerman, G., Shaw, C.R. and Kellermann, M.L. (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 289, 934-937.
52. Kouri, R.E., McKinney, C.E., Slomiany, D.J., Snodgrass, D.R., Wray, N.P. and McLemore, T.L. (1982) Positive correlation between high aryl hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res., 45, 5030-5037.
53. Seidegard, J., Pero, R.W., Markowitz, M.M., Roush, G., Miller, D.G. and Beattie, E.J. (1990) Isoenzyme(s) of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis, 11, 33-36.
54. Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
55. Vineis, P. and Caporaso, N. (1995) Tobacco and cancer: epidemiology and the laboratory. Environ. Health Perspect., 103, 156-160.
56. McWilliams, J.E., Sanderson, B.J.S., Harris, E.L., Richert-Boe, K.E. and Henner, W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 4, 589-594.
57. Cartwright, R.A., Glashan, R.W., Rogers, H.J., Barham-Hall, D., Ahmad, R.A., Higgins, E. and Kahn, M.A. (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacokinetic epidemiological approach to bladder cancer. Lancet, 2, 842-846.
58. Vineis, P., Caporaso, N., Tannenbaum, S.R., Skipper, P.L., Glogowski, J., Bartsch, H., Coda, M., Talaska, G. and Kadlubar, F. (1990) Acetylation phenotype, carcinogen-hemoglobin adducts and cigarette smoking. Cancer Res., 50, 3002-3004.
59. Bartsch, H., Caporaso, N., Coda, M., Kadlubar, F., Malaveille, C., Skipper, P., Talasaka, G. and Tannenbaum, S.R. (1990) Carcinogen hemoglobin adducts, urinary mutagenicity and metabolic phenotype in active and passive cigarette smokers. J. Natl Cancer Inst., 82, 1826-1831.
60. Ilett, K.F., David, B.M., Dethon, P., Castleden, W.M. and Kwa, R. (1987) Acetylation phenotype in colorectral carcinoma. Cancer Res., 47, 1466-1469.
61. Wohlleb, J.C., Hunter, C.F., Blass, B., Kadlubar, F.F., Chu, D.Z.J. and Lang, N.P. (1990) Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int. J. Cancer, 46, 22.
62. Lindahl, T., Wood, R.D. and Karran, P. (1991) Molecular deficiencies in cancer-prone syndromes associated with hypersensitivity to DNA damaging agents. In Brugge, J., Curren, T., Harlow, E. and McCormick, F. (eds) Origins of Human Cancer: A Comprehensive Review. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, NY, pp. 163-170.
63. Pero, R.W., Johnson, D., Markowitz, M., Doyle, G., Lund-Pero, M., Halper, M. and Miller, D.G. (1989) DNA repair synthesis in mononuclear leukocytes of individuals with and without a familial history of cancer. Carcinogenesis, 10, 693-697.
64. 6-methylguanine repair in fibroblast cultures from patients with lung cancer. Cancer Res., 49, 5623-5626.
65. Wei, Q., Gu, J., Cheng, L., Bondy, M.L., Jiang, H., Hong, W.K. and Spitz, M.R. (1996) Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res., 56, 3975-3979.
66. Dybdahl, M., Vogel, U., Frentz, G., Wallin, H. and Nexo, B. (1999) Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 8, 77-81.
67. 1-DNA adducts and glycophorin A variant frequency. Cancer Res., 59, 2557-2561.
68. Hannawalt, P. (1995) DNA repair comes of age. Mutat. Res., 336, 101-113.
69. Hattis, D., Erdreich, L. and DiMauro, T. (1986) Human Variability in Parameters that are Potentially Related to Susceptibility to Carcinogenesis - 1. Preliminary Observations. Center for Technology, Policy and Industrial Development, MIT, Cambridge, MA.
70. Baylin, S., Herman, J., Graff, J., Vertino, P. and Issa, J. (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Cancer Res., 72, 141-196.
71. Weinstein, I. and Zhou, P. (1997) Cell Cycle Control Gene Defects and Human Cancer. Encyclopedia of Cancer. Vol. 1. Academic Press, New York, NY, pp. 256-267.
72. Anonymous (1997) Environmental genome project advances. Environ. Health Perspect., 105, 1298.
73. Collins, F., Patrinos, A., Jordan, E., Chakravarti, A., Gesteland, R. and Walters, L. (1998) New goals for the U.S. Human Genome Project: 1998-2003. Science, 282, 682-689.
74. Dunn, S., Kari, F., French, J., Leininger, J., Travlos, G., Wilson, R. and Barrett, J. (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulate apopotosis, cell proliferation and tumor progression in p53-deficient mice. Cancer Res., 57, 4667-4672.
75. Wilker, E., Bol, D., Kiguchi, K., Rupp, T., Beltran, L. and DiGiovanni, J. (1999) Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor 1 receptor in the epidermis of transgenic mice. Mol. Carcinog., 25, 122-131.
76. Chan, J., Stampfer, M., Giovannucci, E., Gann, P., Ma, J., Wilkinson, P., Hennekens, C. and Pollak, M. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279, 563-566.
77. Hankinson, S., Willett, W., Colditz, G., Hunter, D., Michaud, D., Deroo, B., Rosner, B., Speizer, F. and Pollak, M. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351, 1393-1396.
78. Bruce, W., Archer, M., Corpet, D., Medline, A., Minkin, S., Stamp, D., Yin, Y. and Zhang, X. (1993) Diet, aberrant crypt foci and colorectal cancer. Mutat. Res., 290, 111-118.
79. Chen, J.G.E., Kelsey, K., Rimm, E.B., Stampfer, M.J., Colditz, G.A., Spiegelman, D., Willett, W.C. and Hunter, D.J. (1996) A methylene-tetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res., 56, 4862-4864.
80. Grinberg-Funes, R., Singh, V., Perera, F., Bell, D., Young, T., Dickey, C., Wang, L. and Santella, R. (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype. Carcinogenesis, 15, 2449-2454.
81. Mooney, L.A., Bell, D.A., Santella, R.M., Van Bennekum, A.M., Ottman, R., Paik, M., Blaner, W.S., Lucier, G.W., Covey, L., Young, T.L., Cooper, T.B., Glassman, A.H. and Perera, F.P. (1997) Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18, 503-509.
82. Mueller, N. (1995) Overview: viral agents and cancer. Environ. Health Perspect., 103 (Suppl. 8), 259-261.
83. Gritz, E.R. (1992) Paving the road from basic research to policy: cigarette smoking as a prototype issue for cancer control science. Cancer Epidemiol. Biomarkers Prev., 1, 427-434.
84. Perera, F.P. and Mooney, L.A. (1993) The role of molecular epidemiology in cancer prevention. In DeVita, V.T.Jr, Hellman, S. and Rosenberg, S.A. (eds) Cancer Prevention. J.B. Lippincott Co., Philadelphia, PA, pp. 1-15.
85. Khoury, M.J. and the Genetics Working Group (1996) From genes to public health: the applications of genetic technology in disease prevention. Am. J. Pub. Health, 86, 1717-1722.
86. Sporn, M.B. and Suh, N. (2000) Chemoprevention of cancer. Carcinogenesis, 21, 525-530.